← All candidates
45 insider filings on record.
45 filings on record.
PHATPhathom Pharmaceuticals, Inc.
NasdaqGS · Healthcare · $622.13M
$7.69
-5.76% today
45 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 1 sell
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$622.13M
Float
65.3M
81% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
7.1
Price / sales
2.6
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
40 more transactions on Pro →Context
Wall St
$21.50 avg target
+179.6% vs today · 10 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q2 '26$0.00 act+$0.10
Q1 '26−$0.18 act+$0.01
Q4 '25−$0.08 act+$0.11
Q3 '25−$0.15 act+$0.27
Coverage
PHAT Stock Falls 7% As Leerink Sees Little Near-Term Upside — CEO Plays Down Upcoming RivalStocktwits · 1w agoPhathom Pharmaceuticals (PHAT) Stock Sees Modest Fair Value Cut After Analyst Target CutsSimply Wall St. · 08-16PHAT Stock Clocks Worst Day In Over 1.5 Years — What Sparked The Selloff?Stocktwits · 07-30
The file stays open
45 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice